HUE051831T2 - Szájon át történõ deszenzitizálásra szolgáló földimogyoró-készítmények elõállítása - Google Patents
Szájon át történõ deszenzitizálásra szolgáló földimogyoró-készítmények elõállításaInfo
- Publication number
- HUE051831T2 HUE051831T2 HUE14776121A HUE14776121A HUE051831T2 HU E051831 T2 HUE051831 T2 HU E051831T2 HU E14776121 A HUE14776121 A HU E14776121A HU E14776121 A HUE14776121 A HU E14776121A HU E051831 T2 HUE051831 T2 HU E051831T2
- Authority
- HU
- Hungary
- Prior art keywords
- peanut
- preparations
- preparation
- oral desensitization
- desensitization
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4833—Encapsulating processes; Filling of capsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Transplantation (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Pulmonology (AREA)
- Medical Informatics (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361784964P | 2013-03-14 | 2013-03-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE051831T2 true HUE051831T2 (hu) | 2021-03-29 |
Family
ID=51528061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE14776121A HUE051831T2 (hu) | 2013-03-14 | 2014-03-12 | Szájon át történõ deszenzitizálásra szolgáló földimogyoró-készítmények elõállítása |
Country Status (19)
| Country | Link |
|---|---|
| US (5) | US9198869B2 (https=) |
| EP (3) | EP3998080A1 (https=) |
| JP (3) | JP6752140B2 (https=) |
| CN (2) | CN109125283A (https=) |
| AU (5) | AU2014240404B2 (https=) |
| BR (1) | BR112015021756B1 (https=) |
| CA (1) | CA2903229A1 (https=) |
| DK (2) | DK3482771T3 (https=) |
| ES (2) | ES2826224T3 (https=) |
| FI (2) | FI3482771T3 (https=) |
| FR (1) | FR23C1026I2 (https=) |
| HU (1) | HUE051831T2 (https=) |
| MX (1) | MX2015010315A (https=) |
| NL (1) | NL301236I2 (https=) |
| NO (1) | NO2023027I1 (https=) |
| PL (1) | PL2968529T3 (https=) |
| PT (1) | PT2968529T (https=) |
| SI (1) | SI2968529T1 (https=) |
| WO (1) | WO2014159607A1 (https=) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2924349B1 (fr) | 2007-12-03 | 2010-01-01 | Dbv Tech | Methode de desensibilitation aux allergenes |
| WO2014159609A1 (en) | 2013-03-14 | 2014-10-02 | Allergen Research Corporation | Peanut formulations and uses thereof |
| CN109125283A (zh) * | 2013-03-14 | 2019-01-04 | 艾慕恩治疗公司 | 用于口服脱敏的花生制剂的制备 |
| EP3185900A4 (en) | 2014-08-25 | 2018-05-02 | Aimmune Therapeutics, Inc. | Egg protein formulations and methods of manufacture thereof |
| MA41020A (fr) | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
| US10166286B2 (en) | 2015-02-20 | 2019-01-01 | The Board Of Trustees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
| US10143742B2 (en) | 2015-02-20 | 2018-12-04 | The Board Of Trustees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
| KR20170117562A (ko) | 2015-02-20 | 2017-10-23 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | 혼합 알레르겐 조성물 및 그의 사용 방법 |
| US11452774B2 (en) | 2015-02-20 | 2022-09-27 | The Board Of Trustees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
| US10149904B2 (en) | 2015-02-20 | 2018-12-11 | The Board Of Trusteees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
| TW201709926A (zh) * | 2015-04-23 | 2017-03-16 | 賽諾菲公司 | 用於舌下投藥之吡喃葡萄糖基脂ａ及過敏原調配物 |
| US10856567B2 (en) | 2016-07-22 | 2020-12-08 | Kari Brown | Baby food products containing allergenic proteins and methods of delivering same |
| WO2018104691A1 (en) * | 2016-12-05 | 2018-06-14 | Reacta Biotech Limited | Oral food challenge meal formulations |
| JP2020514306A (ja) * | 2017-01-13 | 2020-05-21 | アイミューン セラピューティクス，インコーポレイテッド | 経口免疫療法用のナッツ粉および製剤の製造方法 |
| AU2017279647B2 (en) | 2017-02-15 | 2022-05-26 | Euroimmun Medizinische Labordiagnostika Ag | An improved assay for the diagnosis of peanut allergy |
| WO2019018529A1 (en) | 2017-07-18 | 2019-01-24 | Before Brands, Inc. | METHODS OF MAKING MIXED ALLERGEN COMPOSITIONS |
| US11369676B2 (en) | 2017-11-02 | 2022-06-28 | Société des Produits Nestlé S.A. | Methods of oral immunotherapy |
| GB201718342D0 (en) * | 2017-11-06 | 2017-12-20 | Cambridge Allergy Ltd | Allergenic protein formulations for immunotherapy |
| AU2019210146A1 (en) | 2018-01-16 | 2020-09-03 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Treatment and prevention of seed allergies |
| EP3829632A4 (en) | 2018-07-27 | 2022-05-04 | Société des Produits Nestlé S.A. | SYSTEMS AND METHODS FOR DELIVERING UNIT DOSES OF ORAL IMMUNOTHERAPY |
| US12433945B2 (en) | 2018-08-16 | 2025-10-07 | Société des Produits Nestlé S.A. | Peanut oral immunotherapy with maintenance dose |
| AU2019401576A1 (en) * | 2018-12-17 | 2021-06-24 | Société des Produits Nestlé S.A. | Formulations for egg oral immunotherapy, methods of manufacture, and treatments for egg allergy |
| US12226448B2 (en) | 2018-12-20 | 2025-02-18 | Société des Produits Nestlé S.A. | Peanut oral immunotherapy dosing schedule for missed doses |
| AU2020213085A1 (en) | 2019-01-23 | 2021-08-12 | Société des Produits Nestlé S.A. | Methods for making mixed allergen compositions |
| CA3137295A1 (en) | 2019-05-10 | 2020-11-19 | Aimmune Therapeutics, Inc. | Methods for improving the quality of life of a patient with a peanut allergy |
| MX2022001568A (es) * | 2019-08-08 | 2022-03-02 | Evonik Operations Gmbh | Procedimiento de preparacion de una forma de dosificacion solida y un lubricante. |
| EP4061753A4 (en) * | 2019-11-20 | 2023-12-13 | Société des Produits Nestlé S.A. | METHODS AND SYSTEMS FOR MANAGING THE DISTRIBUTION AND PROCESSING OF AN ORAL IMMUNOTHERAPY DRUG FOR FOOD ALLERGY |
| KR20220119076A (ko) * | 2019-12-23 | 2022-08-26 | 프로타 테라퓨틱스 피티와이 엘티디 | 약학적 조성물 |
| WO2022003604A1 (en) | 2020-07-01 | 2022-01-06 | Société des Produits Nestlé S. A. | Determining medical staffing for oral immunotherapy |
| EP4274609A1 (en) | 2021-01-08 | 2023-11-15 | Regeneron Pharmaceuticals, Inc. | Methods for treating peanut allergy and enhancing peanut allergen-specific immunotherapy by administering an il-4r antagonist |
| AU2023253754A1 (en) | 2022-04-11 | 2024-10-17 | Alk-Abelló A/S | Peanut allergen composition |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3809767A (en) | 1969-05-12 | 1974-05-07 | Griffith Laboratories | Methods of making vegetable protein concentrates |
| AU1589492A (en) | 1991-03-01 | 1992-10-06 | Warner-Lambert Company | Starch-based controlled release compositions |
| US20120164306A1 (en) * | 1993-08-03 | 2012-06-28 | Girsh Leonard S | Process for preparing hypoallergenic and reduced fat foods |
| JP3445593B2 (ja) * | 1994-09-10 | 2003-09-08 | 株式会社林原生物化学研究所 | ペプチドとその用途 |
| AU2065801A (en) | 1999-12-06 | 2001-06-12 | Panacea Pharmaceuticals, Llc | Passive desensitization |
| AU1951001A (en) * | 2000-04-06 | 2001-09-17 | Panacea Pharm Llc | Microbial delivery system |
| EP1599185A1 (en) * | 2003-02-28 | 2005-11-30 | Alk-Abello A/S | Dosage form having a saccharide matrix |
| EP1734975B1 (en) * | 2004-03-19 | 2015-06-10 | Herbs Spring, LLC | Herbal therapy for the treatment of food allergy |
| BRPI0520821A2 (pt) | 2005-12-28 | 2009-06-30 | Teva Pharma | formulações farmacêuticas de fenofibrato com biodisponibilidade melhorada |
| FR2924349B1 (fr) * | 2007-12-03 | 2010-01-01 | Dbv Tech | Methode de desensibilitation aux allergenes |
| BRPI0921507A2 (pt) | 2008-11-19 | 2016-01-19 | Avantor Performance Mat Inc | composição, método de preparação de um excipiente, comprimido farmacêutico e método de preparação do mesmo |
| US8399519B2 (en) | 2008-12-19 | 2013-03-19 | Merz Pharma Gmbh & Co. Kgaa | 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases |
| US8329208B2 (en) * | 2009-07-28 | 2012-12-11 | Methylation Sciences International Srl | Pharmacokinetics of S-adenosylmethionine formulations |
| EP2364690A1 (en) * | 2010-02-12 | 2011-09-14 | Centro De Ingenieria Genetica Y Biotecnologia | Orally administrable pharmaceutical pellet of epidermal growth factor |
| JP5800527B2 (ja) * | 2010-03-30 | 2015-10-28 | 日東電工株式会社 | 安定化医薬組成物、安定化医薬組成物溶液製剤、フィルム状製剤及びフィルム状製剤の製造方法 |
| AR081776A1 (es) * | 2010-06-30 | 2012-10-17 | Novartis Ag | Composiciones farmaceuticas que comprenden monohidrato de lactato de 4-amino-5-fluoro-3-[6-(4-metil-piperazin-1-il)-1h-bencimidazol-2-il]-1h-quinolin-2-ona, proceso para la produccion de la composicion |
| CN101912364B (zh) * | 2010-08-09 | 2015-07-15 | 刘会梅 | 银杏内酯b脂质体组合药物 |
| GB201104537D0 (en) | 2011-03-17 | 2011-05-04 | Cambridge Entpr Ltd | Treatment for peanut allergy |
| US20140207105A1 (en) * | 2011-08-31 | 2014-07-24 | Perosphere, Inc. | Methods for Effectively and Rapidly Desensitizing Allergic Patients |
| WO2013087119A1 (en) | 2011-12-16 | 2013-06-20 | Hal Allergy Holding B.V. | Pharmaceutical formulations and the use thereof for the treatment of peanut allergy |
| WO2014159609A1 (en) | 2013-03-14 | 2014-10-02 | Allergen Research Corporation | Peanut formulations and uses thereof |
| CN109125283A (zh) | 2013-03-14 | 2019-01-04 | 艾慕恩治疗公司 | 用于口服脱敏的花生制剂的制备 |
| EP3185900A4 (en) | 2014-08-25 | 2018-05-02 | Aimmune Therapeutics, Inc. | Egg protein formulations and methods of manufacture thereof |
| JP2020514306A (ja) | 2017-01-13 | 2020-05-21 | アイミューン セラピューティクス，インコーポレイテッド | 経口免疫療法用のナッツ粉および製剤の製造方法 |
| US11369676B2 (en) | 2017-11-02 | 2022-06-28 | Société des Produits Nestlé S.A. | Methods of oral immunotherapy |
-
2014
- 2014-03-12 CN CN201811093370.9A patent/CN109125283A/zh active Pending
- 2014-03-12 ES ES14776121T patent/ES2826224T3/es active Active
- 2014-03-12 MX MX2015010315A patent/MX2015010315A/es unknown
- 2014-03-12 WO PCT/US2014/024401 patent/WO2014159607A1/en not_active Ceased
- 2014-03-12 EP EP21199373.8A patent/EP3998080A1/en active Pending
- 2014-03-12 PT PT147761217T patent/PT2968529T/pt unknown
- 2014-03-12 US US14/207,165 patent/US9198869B2/en active Active
- 2014-03-12 BR BR112015021756-7A patent/BR112015021756B1/pt active IP Right Grant
- 2014-03-12 DK DK18213124.3T patent/DK3482771T3/da active
- 2014-03-12 ES ES18213124T patent/ES2940686T3/es active Active
- 2014-03-12 PL PL14776121T patent/PL2968529T3/pl unknown
- 2014-03-12 SI SI201431687T patent/SI2968529T1/sl unknown
- 2014-03-12 AU AU2014240404A patent/AU2014240404B2/en active Active
- 2014-03-12 JP JP2016501522A patent/JP6752140B2/ja active Active
- 2014-03-12 EP EP18213124.3A patent/EP3482771B1/en active Active
- 2014-03-12 DK DK14776121.7T patent/DK2968529T3/da active
- 2014-03-12 CN CN201480013792.4A patent/CN105101994B/zh active Active
- 2014-03-12 HU HUE14776121A patent/HUE051831T2/hu unknown
- 2014-03-12 EP EP14776121.7A patent/EP2968529B1/en active Active
- 2014-03-12 FI FIEP18213124.3T patent/FI3482771T3/fi active
- 2014-03-12 CA CA2903229A patent/CA2903229A1/en active Pending
-
2015
- 2015-10-13 US US14/881,437 patent/US20160030289A1/en not_active Abandoned
-
2016
- 2016-09-21 AU AU2016231523A patent/AU2016231523B2/en active Active
-
2017
- 2017-10-24 US US15/792,716 patent/US10449118B2/en active Active
-
2018
- 2018-08-30 AU AU2018222980A patent/AU2018222980A1/en not_active Abandoned
-
2019
- 2019-02-27 JP JP2019034083A patent/JP6891205B2/ja active Active
- 2019-06-26 US US16/453,871 patent/US11141352B2/en active Active
-
2020
- 2020-04-22 AU AU2020202685A patent/AU2020202685B2/en active Active
-
2021
- 2021-02-19 JP JP2021025462A patent/JP7454519B2/ja active Active
-
2022
- 2022-03-17 AU AU2022201858A patent/AU2022201858B2/en active Active
- 2022-09-20 US US17/948,611 patent/US20230120350A1/en not_active Abandoned
-
2023
- 2023-07-03 NL NL301236C patent/NL301236I2/nl unknown
- 2023-07-04 FI FIC20230022C patent/FIC20230022I1/fi unknown
- 2023-07-06 NO NO2023027C patent/NO2023027I1/no unknown
- 2023-07-07 FR FR23C1026C patent/FR23C1026I2/fr active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE051831T2 (hu) | Szájon át történõ deszenzitizálásra szolgáló földimogyoró-készítmények elõállítása | |
| IL254985B (en) | Positioning of components in a user interface | |
| IL242394B (en) | Cenicriviroc compositions and methods of making and using the same | |
| BR112016003454A2 (pt) | Uso de composto de metil bardoxolona | |
| PL2969227T3 (pl) | Formulacja octanu abirateronu | |
| HUE040609T2 (hu) | GLP-1 vegyületek orális adagolása | |
| SI2858671T1 (sl) | Formulacija protiteles | |
| EP3010570A4 (en) | CLINICAL INTERFACE | |
| DK3049441T3 (da) | Anti-PDL1-antistofformuleringer | |
| HUE051982T2 (hu) | Anti-alfa-szinuklein antitestek és alkalmazási eljárások | |
| EP3821931C0 (en) | ORONASAL PATIENT INTERFACE | |
| EP2922514A4 (en) | BI-RADIAL PATIENT INTERFACE | |
| HUE041224T2 (hu) | Deferasziroxot tartalmazó orális készítmények | |
| HUE037048T2 (hu) | Eljárások 4-cikloalkiloxibenzolszulfonamidok elõállítására | |
| HRP20180684T1 (hr) | Kombinacija lijekova | |
| LT2981255T (lt) | Empagliflozino terapiniai panaudojimo būdai | |
| PT3089754T (pt) | Formulações de vacina de dose única | |
| HRP20190101T1 (hr) | Terapeutske uporabe empagliflozina | |
| EP2958994A4 (en) | Vaccine composition | |
| EP2961397A4 (en) | TRANSDERMAL FORMULATIONS | |
| FR3001759B1 (fr) | Rouge aubagee de turbomachine | |
| HRP20181122T1 (hr) | Postupak za pripremu jopamidola | |
| FI20135866L (fi) | Mikrobiologinen keratiinin prosessointi | |
| EP3023416A4 (en) | PREPARATION OF (-) - HUPERZIN-A | |
| IL245167B (en) | Slow-release solid oral compositions |